Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

MLA

Silvia P. Corona, et al. “Addendum: Impact of BMI on the Outcome of Metastatic Breast Cancer Patients Treated with Everolimus: A Retrospective Exploratory Analysis of the BALLET Study.” Oncotarget, vol. 13, Jan. 2022, p. 1307. EBSCOhost, https://doi.org/10.18632/oncotarget.28317.

APA

Silvia P. Corona, Fabiola Giudici, Guy Jerusalem, Eva Ciruelos, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Manuela Milani, Martina Dester, Nicoletta Ziglioli, Giuseppina Barbieri, Valeria Cervoni, Filippo Montemurro, & Daniele Generali. (2022). Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study. Oncotarget, 13, 1307. https://doi.org/10.18632/oncotarget.28317

Chicago

Silvia P. Corona, Fabiola Giudici, Guy Jerusalem, Eva Ciruelos, Carla Strina, Marianna Sirico, Ottavia Bernocchi, et al. 2022. “Addendum: Impact of BMI on the Outcome of Metastatic Breast Cancer Patients Treated with Everolimus: A Retrospective Exploratory Analysis of the BALLET Study.” Oncotarget 13 (January): 1307. doi:10.18632/oncotarget.28317.